For Advanced Lung Cancer, Immune Therapy Plus Chemo Prolongs Survival | Latest News RSS feed

For Advanced Lung Cancer, Immune Therapy Plus Chemo Prolongs Survival - Latest News


For advanced lung cancer, immune therapy plus chemo prolongs survival

Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus standard chemotherapy lived significantly longer than those who got chemo alone, according to a new study tha... read more

New hope for lung cancer patients Study: Immunotherapy plus chemo prolongs survival

Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus ... therapy group who were alive and whose disease had not gotten worse at a year was about 34 percent, about ... read more

Immune therapy scores big win against lung cancer in study

Another study found that an immunotherapy combo — the Bristol-Myers Squibb drugs Opdivo and Yervoy — worked better than chemo for delaying the time until cancer worsened in advanced lung ... survival, ... read more

Looking for another news?


EC Approves Frontline Lung Cancer Combo

The European Commission has approved the combination of pembrolizumab (Keytruda, Merck), pemetrexed (Alimta, Lilly), and platinum chemotherapy for the first-line treatment of metastatic non–small cell ... read more


Immune therapy scores big win against lung cancer in study

For the first time, a treatment that boosts the immune system greatly improved survival ... chemo for the most common form of advanced lung cancer, but doctors have been leery to use it because that w... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us